Dolutegravir Sodium Structural Formula (Dovato Spl Graphic 01)
Dovato Tablet, Film Coated
Product Images NDC 49702-246
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dovato (NDC 49702-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lamivudine Structural Formula (Dovato Spl Graphic 02)
Dovato 30 Count Label (Dovato Spl Graphic 03)
Dovato is a prescription medication in the form of tablets. It is a combination of dolutegravir and lamivudine, with each tablet containing 50 mg of dolutegravir (equivalent to 525 mg of dolutegravir sodium) and 300 mg of lamivudine. The package contains 30 tablets and has an alert on the box not to be covered with the pharmacy label. The medicine should not be taken with certain other medications. The package is tamper-evident, and the tablets should be stored below 30°C (86°F) and out of reach of children. Further dosage information can be found in the prescribing information. The manufacturer of Dovato is ViV Healthcare, which owns or licenses the trademarks.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
